The InnoSIGN team hopes to welcome you at booth#1153 during the San Antonio Breast Cancer Symposium (SABCS), from Wednesday December 6 to Friday 8 December, 2023.
An abstract by NYU-Langone and two abstracts by InnoSIGN have been selected for poster presentation in the scientific program.
If you want to learn more about OncoSIGNal pathway profiling in breast cancer please visit us at the InnoSIGN booth and poster presentations.
Posters presentations:
Thursday, December 7th, 5:00 – 7:00pm
Poster#: PO4-26-06 Authors: Chanel Schroff et al, NYU Langone Health
“Identifying mutation-independent signaling pathway activation in molecular subtypes of triple negative breast cancers”.
Saturday, December 8th, 12:00 – 2:00pm
Poster#: PO5-13-10 Authors: Paul van de Wiel et al, InnoSIGN
“Determining tumor-driving cell signaling pathways in breast cancer: Support for targeted therapy selection”.
Poster#: PO5-21-06 Authors: Sigi Neerken et al, InnoSIGN
“Pathway profiling for prediction of response to neoadjuvant Letrozole therapy in ER positive postmenopausal breast cancer: gaining new insights for targeted treatment”.
